Tarbox Family Office, Inc. Nektar Therapeutics Transaction History

Tarbox Family Office, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$14.47 - $27.96 $332 - $643	-23 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$31.0 - $36.3 $434 - $508	14 Added 155.56%	23 $1,000
Q4 2018 Feb 01, 2019	BUY	$30.43 - $56.65 $273 - $509	9 New	9 $0
Q2 2018 Jul 31, 2018	SELL	$46.25 - $104.45 $185 - $417	-4 Closed	0 $0
Q1 2018 Apr 25, 2018	BUY	$57.4 - $108.44 $229 - $433	4 New	4 $0

145

139M

32.6K

14.1K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $178M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Tarbox Family Office, Inc., based on Form 13F filings with the SEC.

Stay updated on Tarbox Family Office, Inc. with notifications on news.